Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 77Recruiting 21Terminated 16Active not recruiting 13Unknown 7Withdrawn 4Not yet recruiting 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 2Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Ovarian Neoplasms 12Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Peritoneal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Vulvar Diseases 1Uterine Neoplasms 1Tissue Adhesions 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Ovarian Cysts 1Osteosarcoma 1Obesity 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lichen Sclerosus et Atrophicus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Small Cell Lung Carcinoma × Gynecologic × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡